12 completed, 12 recruiting, 7 unknown, 3 active not recruiting. 17 Not applicable, 6 Phase 2, 5 Phase 3, 2 Phase 1, 1 Phase 4.
Follow Urologic Cancer: new trials by email Literature Review of Urologic Cancer trials Research Report on Urologic Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer NDV-01 (sustained-release gemcitabine-docetaxel) - Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) | Phase 3 | Not yet recruiting | Relmada Therapeutics, Inc. | 393 | 2027-02-01 | 2026-09-02 |
| Prediction of Myocardial Injury After Non-Cardiac Surgery in Urologic Cancer Patients No intervention assigned - Myocardial Injury After Non-cardiac Surgery, Urologic Cancer | Recruiting | Korea University Anam Hospital | 200 | 2026-07-15 | 2026-07-22 | |
| A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy NDV-01 (sustained-release gemcitabine-docetaxel) - Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) | Phase 3 | Withdrawn | Relmada Therapeutics, Inc. | 2026-06-30 | 2026-03-17 | |
| A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT NDV-01 (sustained-release gemcitabine-docetaxel) - Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Bladder (Urothelial, Transitional Cell) Cancer | Phase 3 | Withdrawn | Relmada Therapeutics, Inc. | 2026-05-01 | 2026-03-17 | |
| Vaginal Dilator Therapy After Pelvic Radiation Improving Engagement with Vaginal Dilator Therapy after Pelvic Radiation - Pelvic Radiotherapy, Vaginal Stenosis | Not applicable | Recruiting | Duke University | 130 | 2026-03-05 | 2026-07-22 |
| Interest of Magnetic Resonance Imaging in the Diagnosis of Upper Urinary Tract Invasive Tumours Upper urinary tract magnetic resonance imaging - Magnetic Resonance Imaging (MRI), Urologic Cancer | Not applicable | Not yet recruiting | University Hospital, Toulouse | 178 | 2025-12-01 | 2025-11-28 |
| In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients blood collection, tissue specimen collection - Head and Neck Cancer, Urologic Cancer | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 640 | 2025-04-30 | 2025-02-14 | |
| Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy CIPN assessment, EV blood analysis - Chemotherapy-Induced Peripheral Neuropathy, Breast Cancer | Not applicable | Recruiting | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 120 | 2025-01-01 | 2026-04-30 |
| Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors Palliative radiotherapy - Gastrointestinal Cancer, Urologic Cancer | Not applicable | Recruiting | Sykehuset Telemark | 200 | 2024-12-10 | 2025-05-23 |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy Rivaroxaban 10 MG, Placebo control - Venous Thromboembolism, Urologic Cancer | Phase 2 / Phase 3 | Recruiting | Ottawa Hospital Research Institute | 120 | 2024-11-04 | 2025-07-10 |
| Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary） Urologic Cancer | Recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 150 | 2024-08-01 | 2024-08-05 | |
| Comparison of the Integrated Posterior-Anterior-Lateral Approach and the Posterior Approach in Robotic Radical Prostatectomy PAL combined approach group, posterior approach group - Urologic Cancer, Prostate | Not applicable | Completed | The First Affiliated Hospital of Zhengzhou University | 60 | 2024-05-16 | 2025-12-26 |
| Telemedicine for Postoperative Follow-up After Oncological Surgeries Type of post-operative appointment - Urologic Cancer, Satisfaction, Patient | Unknown | Instituto do Cancer do Estado de São Paulo | 200 | 2024-03-01 | 2024-02-28 | |
| A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT Cretostimogene Grenadenorepvec, n-dodecyl-B-D-maltoside - Non Muscle Invasive Bladder Cancer, Urologic Cancer | Phase 3 | Active not recruiting | CG Oncology, Inc. | 367 | 2023-12-14 | 2026-07-01 |
| Fluid Challenge and Plasma Volume, During Surgery acetated Ringers, albumin 5%, albumin 20% - Colorectal Cancer, Urologic Cancer | Phase 4 | Recruiting | Joachim Zdolsek | 60 | 2023-10-23 | 2026-04-30 |
| PROM Project Urology Observation of patients undergoing sugery - Surgery, Urologic Diseases | Recruiting | Medical University of Graz | 47 | 2023-09-05 | 2024-05-02 | |
| Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients Web-Based Application for PROM Monitoring During Radiotherapy - Gynecologic Cancer, Urologic Cancer | Not applicable | Recruiting | Institute of Oncology Ljubljana | 30 | 2023-09-02 | 2026-02-24 |
| A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest Electromagnetic Guided Laparoscopy, Ultrasound - Urologic Cancer, Urologic Neoplasms | Not applicable | Completed | Brigham and Women's Hospital | 7 | 2023-08-30 | 2026-09-30 |
| Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy Maltodextrin 12.5%, Water - Anesthesia, Urologic Cancer | Not applicable | Unknown | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 66 | 2023-03-30 | 2023-06-22 |
| The Registry of Genetic Expression of Taiwan Urologic Cancer Urologic Cancer | Active not recruiting | National Health Research Institutes, Taiwan | 500 | 2023-01-07 | 2025-05-22 |
Showing 20 of 43. Sign in to see all of them.
Urologic Neoplasms (43) · Neoplasms (9) · Urinary Bladder Neoplasms (9) · Breast Neoplasms (6) · Head and Neck Neoplasms (6) · Kidney Neoplasms (5) · Non-Muscle Invasive Bladder Neoplasms (5) · Carcinoma, Renal Cell (4) · Lung Neoplasms (4) · Carcinoma, Transitional Cell (3) · Colonic Neoplasms (3) · Gastrointestinal Neoplasms (3) · Prostatic Neoplasms (3) · Stomach Neoplasms (3) · Urologic Diseases (3)
Female Urogenital Diseases (43) · Female Urogenital Diseases and Pregnancy Complications (43) · Male Urogenital Diseases (43) · Neoplasms by Site (43) · Urogenital Diseases (43) · Urogenital Neoplasms (41) · Urologic Diseases (40) · Neoplasms (34) · Neoplasms by Histologic Type (13) · Carcinoma (9) · Digestive System Diseases (9) · Digestive System Neoplasms (9) · Gastrointestinal Diseases (9) · Neoplasms, Glandular and Epithelial (9) · Urinary Bladder Diseases (9)
dodecyl maltoside (2) · Administration, Intravesical (1) · Albumins (1) · Biological Therapy (1) · Blood Specimen Collection (1) · Control Groups (1) · Docetaxel (1) · Immunoglobulins, Intravenous (1) · Lidocaine (1) · Meditation (1) · Neoadjuvant Therapy (1) · Ringer's acetate (1) · Rivaroxaban (1) · Saline Solution (1) · Tissue Banks (1)
Relmada Therapeutics, Inc. (3) · Brigham and Women's Hospital (2) · CG Oncology, Inc. (2) · Samsun Liv Hospital (2) · Assistance Publique Hopitaux De Marseille (1) · Duke University (1) · Exosome Diagnostics, Inc. (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Fundacio Puigvert (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · GammaCan (1) · Herlev and Gentofte Hospital (1) · IRCCS San Raffaele (1) · Imperial College London (1) · Insel Gruppe AG, University Hospital Bern (1)
United States (11) · France (3) · Germany (3) · Canada (2) · China (2) · Italy (2) · South Korea (2) · Spain (2) · Switzerland (2) · Turkey (Türkiye) (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Denmark (1) · Israel (1)
Matthew Mossanen, MD (2) · Christian Fankhauser, PD Dr. med. (1) · Christian Gratzke, Prof. Dr. (1) · Clara Rosso, PhD (1) · Dan Aderka, M.D. (1) · Donald Lamm, MD, FACS (1) · Dong Hyuck Cho, MD, PhD (1) · Ender Ozden, Prof. (1) · Ender Ozden, Professor (1) · Harald Ragnum, MD,PhD (1) · Hashim Ahmed, PhD, FRCS (1) · Ida Marie L Rasmussen, MD (1) · Joachim Zdolsek, MD PhD (1) · Jochen Renner, Prof. Dr. (1)
PMID 18632142, PMID 22915180, PMID 23937616, PMID 24013181, PMID 26251228, PMID 27614693, PMID 27988238, PMID 31616454, PMID 31647691, PMID 31677114, PMID 32967451, PMID 34449941, PMID 34794989, PMID 35084544, PMID 35314720, PMID 36017553, PMID 36038883, PMID 37468392, PMID 38265030, PMID 38642892, PMID 39422911, PMID 40597814
2017 (1), K08CA304375 (1)